Medicine and Dentistry
Biochemical Recurrence
14%
Biopsy Technique
41%
Bladder Cancer
45%
Body Image
10%
Bone Morphogenetic Protein
23%
Bone Morphogenetic Protein Receptor 1A
12%
Bone Morphogenetic Protein Receptor 2
20%
Cancer Cell
14%
Cancer Diagnosis
10%
Cancer Growth Factor
16%
Cancer Tissue
17%
Clear Cell Carcinoma
10%
Clinical Study
10%
Clomipramine
20%
Continence
24%
Cystectomy
88%
Diagnosis
15%
Ejaculation
10%
Fat Pad
15%
Gleason Score
26%
Growth Factor Receptor
15%
Hazard Ratio
11%
Immunohistochemistry
10%
Kidney Tumour
10%
Lower Urinary Tract Symptom
27%
Lymph Node
24%
Malignant Neoplasm
20%
Metastatic Carcinoma
15%
Micropapillary
11%
Neobladder
66%
Neoplasm
58%
Paralytic Ileus
10%
Percutaneous Nephrolithotomy
10%
Placebo
17%
Premature Ejaculation
20%
Prostate Biopsy
17%
Prostate Cancer
100%
Prostate Hypertrophy
20%
Prostate Specific Antigen
67%
Prostatectomy
20%
Recurrent Disease
11%
Retrospective Cohort Study
20%
Retrospective Study
16%
Robot-Assisted Prostatectomy
74%
Surgical Margin
11%
Telomerase
31%
Transitional Cell Carcinoma
86%
Transurethral Resection
14%
Tumor Progression
15%
Urinary Diversion
10%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Pyelonephritis
10%
Adverse Event
11%
Alfuzosin
10%
Alpha Adrenergic Receptor Blocking Agent
14%
Antibiotics
19%
Antihypertensive Agent
20%
Bladder Cancer
34%
Bladder Tumor
7%
Bone Morphogenetic Protein
23%
Bone Morphogenetic Protein Receptor 1A
12%
Bone Morphogenetic Protein Receptor 2
20%
C Reactive Protein
10%
Cancer Growth Factor
16%
Chronic Prostatitis
7%
Cisplatin
12%
Clinical Study
12%
Clomipramine
10%
Cohort Study
25%
Dizziness
8%
DNA Fragment
10%
Erectile Dysfunction
20%
Escherichia coli
17%
Growth Factor Receptor
15%
Hematuria
7%
Hypertension
20%
Immunotherapy
12%
Intestine Obstruction
10%
Lipopolysaccharide
10%
Lower Urinary Tract Symptom
7%
Malignant Neoplasm
13%
Membrane Receptor
15%
Muscle Invasive Bladder Cancer
15%
Neoplasm
51%
Paralytic Ileus
14%
Phosphodiesterase V Inhibitor
10%
Placebo
10%
Premature Ejaculation
10%
Programmed Death 1 Ligand 1
20%
Prostate Cancer
42%
Prostate Hypertrophy
20%
Prostate Specific Antigen
23%
Prostatitis
20%
Recurrent Disease
11%
Sildenafil
20%
Telomerase
10%
Tolerability
10%
Transitional Cell Carcinoma
49%
Tumor Growth
17%
Tumor Recurrence
8%
Urinary Tract Infection
12%